Gregory Bailey founded Palantir Group Inc., which made successful investments in bio‑tech start‑ups and financings. He is co‑founder and currently Executive Chair of Juvenescence Ltd. In addition, he serves as a Non‑executive Director of Serina Therapeutics Inc. and Biohaven Ltd, both listed on the NYSE. Furthermore, he is founder and Chair of Chelsea Avondale, a property and casualty insurance company, and founder and Chair of Culminant Reinsurance. With comprehensive experience in finance and healthcare, he has served on numerous public company boards and brings to the Group extensive expertise in corporate governance.
Appointment
Appointed to the Board on 7 February 2018.